跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 61,529 条关于
“spinocerebellar ataxia type 3”
全部
61,529
临床试验
39,313
药物
5,198
机构
1,408
资讯
15,610
去年
CIRM Awards $5.69M Grant to Advance Novel Gene Therapy for Spinocerebellar Ataxia Type 3
8个月前
Sarepta Therapeutics Submits Clinical Trial Application for SRP-1005 Huntington's Disease Treatment
6个月前
Vico Therapeutics Advances VO659 with Twice-Annual Dosing in Phase 1/2 Trial for Huntington's Disease and Spinocerebellar Ataxias
去年
Vico Therapeutics' VO659 Shows Promise in Huntington's Disease and Spinocerebellar Ataxias
去年
Transcranial Magnetic Stimulation Shows Promise in Treating Multiple System Atrophy
去年
Solaxa Advances SLX-100 to Phase 3 Trial for Rare Spinocerebellar Ataxia Type 27B
去年
L-Arginine Shows Promise but Falls Short of Statistical Significance in Spinocerebellar Ataxia Type 6 Trial
去年
Biohaven Withdraws EU Application for Spinocerebellar Ataxia Drug Dazluma
去年
FDA Grants Priority Review to Troriluzole for Spinocerebellar Ataxia Treatment
10个月前
FDA Issues Complete Response Letter for Biohaven's VYGLXIA (troriluzole) for Spinocerebellar Ataxia
第 1 页，共 1561 页
上一页
下一页
